I am a breastfeeding mother and i want to know if it is safe to use McN 4853? Is McN 4853 safe for nursing mother and child? Does McN 4853 extracts into breast milk? Does McN 4853 has any long term or short term side effects on infants? Can McN 4853 influence milk supply or can McN 4853 decrease milk supply in lactating mothers?
- DrLact safety Score for McN 4853 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of McN 4853 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that McN 4853 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of McN 4853 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Anticonvulsant used for treatment of epilepsy and migraine prophylaxis. It is moderately excreted into breast milk with the infant receiving just over 10% of the maternal weight-adjusted dose. Neither clinical nor psychomotor developmental effects have been observed in infants whose mothers were treated. Only a possibly related case of gastroenteritis that resolved after discontinuation of mother’s medication.Plasma levels of infants whose mothers were treated with McN 4853 have shown to be undetectable or pretty below (<1 mg / L) the recommended therapeutic level (5-20 mg / L). Check up the occurrence of diarrhea, irritability and lethargy in infants
Limited information indicates that maternal doses of McN 4853 up to 200 mg daily produce relatively low levels in infant serum. Monitor the infant for diarrhea, drowsiness, irritability, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsant or psychotropic drugs.
No adverse effects were observed in 3 infants who were breastfed from birth and observed for at least 24, 27 and 97 days.[1] The authors reported 3 additional breastfed infants who also had no adverse effects.[4] An exclusively breastfed infant whose mother was taking McN 4853 300 mg, levetiracetam 2 g, and valproate 1.8 g daily during pregnancy and lactation appeared healthy to the investigators throughout the 6- to 8-week study period.[5] One woman breastfed her infant for 13 months while she was taking McN 4853 for epilepsy. She took a daily dosage of 150 to 175 mg for the first 6 months, then 200 mg daily. At 1 year of age, the infant was developing normally and both parents stated that no side effects such as tiredness had been observed in the infant.[2] A woman who took McN 4853 300 mg daily throughout pregnancy delivered a normal, healthy infant. She reportedly breastfed her infant exclusively for 8 months at which time no adverse drug effects or neurodevelopmental delay were noted by the infant's pediatrician.[6]The breastfed infant of a mother who was taking 100 mg of McN 4853 daily developed watery, foamy stools with 8 to 10 bowel movements daily at 40 days of age. The infant's rate of weight gain also declined. McN 4853 was detected in breastmilk at a relatively high concentration. Two weeks later, breastfeeding was discontinued. Within 24 hours, the stool frequency declined to 2 to 3 times daily, more solid and the color and odor normalized.[3] McN 4853 was the probable cause of the diarrhea in the infant.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.